The role of pharmacology in anticancer drug development
Drug development consists of many sequential and parallel steps; failure in one of the steps can lead to discontinuation of the process. The process is time-consuming and very expensive, especially the clinical phase. In order to enhance cancer drug development in the 1980s, the National Cancer Inst...
Saved in:
Main Authors: | Godefridus J. Peters (Author), Anne-Sophie Govaerts (Author), Hans R. Hendriks (Author), for EORTC Pharmacology and Molecular Mechanism Group (Author) |
---|---|
Format: | Book |
Published: |
International Association of Physical Chemists (IAPC),
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors
by: Godefridus J. Peters, et al.
Published: (2016) -
Acknowledgment to the Reviewers of <i>Future Pharmacology</i> in 2022
by: Future Pharmacology Editorial Office
Published: (2023) -
The role of l-leucovorin uptake and metabolism in the modulation of 5-fluorouracil efficacy and antifolate toxicity
by: Godefridus J. Peters, et al.
Published: (2024) -
Mechanisms of P-Glycoprotein Alteration During Anticancer Treatment: Role in the Pharmacokinetic and Pharmacological Effects of Various Substrate Drugs
by: Takuro Kobori, et al.
Published: (2014) -
Selenium-Based Drug Development for Antioxidant and Anticancer Activity
by: Sashi Debnath, et al.
Published: (2022)